International Drug & Explosives Detection Company Identa Corp Receives American Patent

Jun 21, 2010, 09:58 ET from IDenta Corp.

JERUSALEM, Israel, June 21, 2010 /PRNewswire-FirstCall/ -- Identa Corp. (PINKSHEETS: IDTA) CEO Yaacov Shoham today issued the following statement concerning a recently acquired US patent on the casing for drug, explosive and precursor test kits.

"We have received an American patent for the plastic casing that we use for the drug, explosive and precursor test kits. It took a very long time because we had to respond to all the claims regarding the new and unique type of the casing. Identa Corp is very pleased with the awarding of the patent We feel and believe that our casing is superior to all others because the main feature of the casing is to protect the end user as much as is possible and make the detection an easy and reliable process.

Information concerning Identa's entire product line (including the casing) may be found at http://www.IDenta.biz

ABOUT IDENTA

Since 2003, Identa Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. Identa develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

DISCLAIMER

Certain statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning Identa's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, Identa Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, http://www.identa.biz.

    Contact:
    Yaacov Shoham
    Identa Corp.
    CEO
    Tel: +972-52-6554487
    fpi@drugsdetector.com


    http://www.identa.biz

SOURCE IDenta Corp.